ANO1 and cancer: Although some TMEM16A inhibitors have been tested in certain cancer cell lines [111, 136, 139], it remains unclear whether these compounds can effectively inhibit cancer growth in vivo, since pharmacological sensitivity of TMEM16A channels may be affected by cellular environment [10, 140, 141].